{
    "clinical_study": {
        "@rank": "13328", 
        "arm_group": [
            {
                "arm_group_label": "Waiting list group", 
                "arm_group_type": "Other", 
                "description": "This group will receive the same treatment of the experimental group after the test-retest measurements."
            }, 
            {
                "arm_group_label": "Experimental group: aerobic exercise", 
                "arm_group_type": "Experimental", 
                "description": "This group will receive the treatment with aerobic exercise training"
            }
        ], 
        "brief_summary": {
            "textblock": "This study has been designed in order to know the effect of 12 weeks of aerobic exercise\n      training for migraine prevention. We hypothesized that the exercise training could reduce\n      the number of days with migraine and the number of attacks per month in the treated group."
        }, 
        "brief_title": "The Effect of Aerobic Exercise Training for Migraine Prevention.", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Headache Disorders, Primary", 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders", 
                "Headache Disorders", 
                "Headache Disorders, Primary"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will cover 16 weeks. The first 4 weeks has been designed as \"baseline\" period, to\n      assess the migraine status and classification, colect blood exam, perform a cardiopulmonary\n      exercise test to determine the maximal oxygen uptake, and fill psychometric questionnaires.\n      The remaining 12 weeks will be the \"intervention\" period, where participants after\n      randomization will be allocated to perform an aerobic exercise training (on treadmill)\n      performed on a 3 times per week-based program of 40-min duration each session, or will wait\n      for the equal period to repeat all the assessments, then  begin the same exercise protocol."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Sedentary (> 6 month) healthy subjects and sedentary (> 6 month)subjects with\n             migraine without aura, migraine with aura and chronic migraine;\n\n        Exclusion Criteria:\n\n          -  Physically active(> 1 day/week);\n\n          -  Tobacco user;\n\n          -  Alcohol or abuse drug user;\n\n          -  Taking any prescribed medication or, in the case of medication for migraine\n             prevention, if taking < 6 months.\n\n          -  Having any cardiovascular, pulmonary, endocrine-metabolic, rheumatic or other\n             neurologic disease or psychiatric disorder such as bipolar disorder and\n             post-traumatic stress syndrome.\n\n          -  Undergoing surgical procedure less than 3 months before entering the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01972607", 
            "org_study_id": "081511"
        }, 
        "intervention": {
            "arm_group_label": [
                "Waiting list group", 
                "Experimental group: aerobic exercise"
            ], 
            "description": "12 weeks of aerobic exercise training performed 3x/week at moderate intensity with sessions of 40 min.", 
            "intervention_name": "Exercise Training", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Migraine, aerobic exercise, prevention", 
        "lastchanged_date": "October 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "04021-001"
                }, 
                "name": "Federal University of Sao Paulo"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Aerobic Exercise Training for Migraine Prevention.", 
        "other_outcome": {
            "measure": "Maximal Oxygen Uptake", 
            "safety_issue": "No", 
            "time_frame": "Measurements of the maximal oxygen uptake has been performed at Week 1, which is set as \"baseline\" measurement, and at week 16, which is set as \"post-intervention\" measurement."
        }, 
        "overall_official": {
            "affiliation": "Federal University of Sao Paulo", 
            "last_name": "Mario FP Peres, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Frequency of Migraine/month", 
            "safety_issue": "No", 
            "time_frame": "Migraine frequency measured between the first and 4th weeks has been set as the \"baseline\" period,  and  will be compared to changes in frequency measured between weeks 12 to 16, which has been set as \"post-intervention\" period."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01972607"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Federal University of S\u00e3o Paulo", 
            "investigator_full_name": "Ar\u00e3o Belitardo de Oliveira", 
            "investigator_title": "Prof. BS. Ar\u00e3o Belitardo de Oliveira", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Days with Migraine", 
            "safety_issue": "No", 
            "time_frame": "Days with migraine measured between the first and 4th weeks has been set as the \"baseline\" period,  and  will be compared to changes in days with migraine measured between weeks 12 to 16, which has been set as \"post-intervention\" period"
        }, 
        "source": "Federal University of S\u00e3o Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Federal University of S\u00e3o Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}